VRTX FY 2021 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena

VRTXVertex Pharmaceuticals Incorporated

$129B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7.6B+22.1% YoY

Gross Profit

$6.7B88.1% margin

Operating Income

$2.8B36.7% margin

Net Income

$2.3B30.9% margin

EPS (Diluted)

$9.01

Cash Flow

Operating Cash Flow

$2.6B

Free Cash Flow

$2.4B

Stock-Based Comp.

$441M

Balance Sheet

Total Assets

$13.4B

Total Liabilities

$3.3B

Stockholders' Equity

$10.1B

Cash & Equivalents

$6.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.6B	$6.2B	+22.1%
Gross Profit	$6.7B	$5.5B	+22.0%
Operating Income	$2.8B	$2.9B	-2.6%
Net Income	$2.3B	$2.7B	-13.6%